Learn More
Medchemexpress LLC 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-N-(6-phenyl-3-pyridazinyl)-7H-purine-7-acetamide | 1638250-96-0 | MFCD29472267 | ≥95.0% | 391.4 | C19H17N7O3 | 10 MG

Supplier: Medchemexpress LLC HY1898810MG
ETC-159 is a potent, orally available porcupine (PORCN) inhibitor used in research to block Wnt ligand secretion and Wnt/β-catenin signaling. It inhibits β-catenin reporter activity with a reported IC50 of 2.9 nM and has been evaluated in preclinical and early clinical studies for Wnt-dependent cancers. Typical supplier purity is ≥95% and the compound is supplied as a crystalline solid.
- Potent PORCN inhibition with low nanomolar activity.
- Orally bioavailable for in vivo research applications.
- Blocks Wnt ligand secretion and downstream β-catenin signaling.
- Reported β-catenin reporter IC50 ~2.9 nM.
- High purity (≥95%) and crystalline solid form.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.